SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-12-008964
Filing Date
2012-02-14
Accepted
2012-02-14 21:40:12
Documents
1
Period of Report
2012-02-13

Document Format Files

Seq Description Document Type Size
1 F4 EYLER rrd334092.html 4  
1 F4 EYLER rrd334092.xml 4 4120
  Complete submission text file 0001181431-12-008964.txt   5594
Mailing Address 10940 WILSHIRE BLVD. SUITE 600 LOS ANGELES CA 90024
Business Address
EYLER CHARLES R (Reporting) CIK: 0001358246 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-52811 | Film No.: 12614082

Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Issuer) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations